TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32887762

Group type: EXPERIMENTAL
Intervention: Combined scatter correction (CC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No correction (NC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Scatter correction (SC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Attenuation correction (AC)
Number of subjects: 20
Study: 36371189

Group type: EXPERIMENTAL
Intervention: Intraoral scanning of the scan body
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Conventional closed tray impression technique
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Conventional open tray impression technique
Number of subjects: 8

Group type: COMPARATOR
Intervention: Reference group (intraoral scanning of the abutment)
Number of subjects: 8
Study: 32088110

Group type: EXPERIMENTAL
Intervention: Metabolic surgery
Number of subjects: 57
Study: 34972039

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 42
Study: 33743869

Group type: EXPERIMENTAL
Intervention: Pan-immunoglobulins against SARS-CoV-2
Number of subjects: 9702

Group type: EXPERIMENTAL
Intervention: IgM antibodies
Number of subjects: 9702

Group type: EXPERIMENTAL
Intervention: IgA antibodies
Number of subjects: 9702

Group type: EXPERIMENTAL
Intervention: IgG antibodies
Number of subjects: 9702

Group type: EXPERIMENTAL
Intervention: Neutralising antibodies
Number of subjects: 9702

Group type: EXPERIMENTAL
Intervention: Neutralising antibodies over time
Number of subjects: 9702

Group type: EXPERIMENTAL
Intervention: IgG antibodies over time
Number of subjects: 9702
Study: 35488213

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) and Motor Imagery (MI) in addition to Physical Therapy (PT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Physical Therapy (PT)
Number of subjects: 44
Study: 32028501

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine
Number of subjects: 125

Group type: COMPARATOR
Intervention: Nonbuffered lidocaine
Number of subjects: 125
Study: 34226926

Group type: EXPERIMENTAL
Intervention: Group A - Lower second molar tubes bonded at the time of 0.016" x 0.022" NiTi wire placement
Number of subjects: 36

Group type: COMPARATOR
Intervention: Group B - Lower second molars bonded at the first appointment
Number of subjects: 36
Study: 33579288

Group type: EXPERIMENTAL
Intervention: Dual therapy (long-acting beta-2 agonist [LABA] or long-acting muscarinic antagonist [LAMA]) in GOLD III/IV group
Number of subjects: 14449

Group type: EXPERIMENTAL
Intervention: Dual therapy in GOLD III/IV group
Number of subjects: 14449

Group type: EXPERIMENTAL
Intervention: Dual therapy in GOLD I/II group
Number of subjects: 14449
Study: 32005334

Group type: EXPERIMENTAL
Intervention: ACT combined with the smartphone application
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: ACT
Number of subjects: 150

Group type: COMPARATOR
Intervention: Behavioral support
Number of subjects: 150
Study: 33836476

Group type: EXPERIMENTAL
Intervention: Intramuscular ACTH
Number of subjects: 65

Group type: COMPARATOR
Intervention: Oral Prednisolone
Number of subjects: 65
Study: 32635790

Group type: EXPERIMENTAL
Intervention: Genetically predicted hemoglobin
Number of subjects: 265424
Study: 35988661

Group type: EXPERIMENTAL
Intervention: sEMG-BF (surface EMG biofeedback)
Number of subjects: 80

Group type: COMPARATOR
Intervention: continued care (no intervention)
Number of subjects: 80
Study: 33639999

Group type: EXPERIMENTAL
Intervention: Endosonography without confirmatory mediastinoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endosonography with confirmatory mediastinoscopy
Number of subjects: 0
Study: 34009907

Group type: EXPERIMENTAL
Intervention: Rapid Cycle Deliberate Practice (RCDP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Postsimulation Debriefing (PSD)
Number of subjects: 32
Study: 32041441

Group type: EXPERIMENTAL
Intervention: Microneedling with topical tacrolimus at 2 weeks intervals for a maximum of 6 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Tacrolimus 0.1% ointment applied once daily for 6 months
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Microneedling with topical tacrolimus
Number of subjects: 48
Study: 32692071

Group type: EXPERIMENTAL
Intervention: Synoptic reporting
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Urban hospital settings
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Time (2005 vs 2010)
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Synoptic reporting adoption (2005 vs 2010)
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Overall adherence to guidelines
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Tumor histologic grade reporting
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Radial margin reporting
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Distance from the closest margin reporting
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Treatment effect reporting
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Lymphovascular invasion reporting
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Perineural invasion reporting
Number of subjects: 1004
Study: 36031846

Group type: EXPERIMENTAL
Intervention: Triamcinolone irrigation (4 ml of 40mg/ml solution)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Saline irrigation (control)
Number of subjects: 58
Study: 34397028

Group type: EXPERIMENTAL
Intervention: Adhesive retainer group
Number of subjects: 38

Group type: COMPARATOR
Intervention: Modified adhesive retainer group
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study: 34698502

Group type: EXPERIMENTAL
Intervention: Immediate Genotypic Resistance Testing (GRT)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 840
Study: 32107270

Group type: EXPERIMENTAL
Intervention: Daily sunscreen use (prevention)
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Annual clinical skin examinations (early detection)
Number of subjects: 100000

Group type: COMPARATOR
Intervention: No intervention (status quo)
Number of subjects: 100000
Study: 34893415

Group type: EXPERIMENTAL
Intervention: Low-starch high-fiber pasta (LSHFP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rice
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard pasta (SP)
Number of subjects: 20
Study: 34162968

Group type: EXPERIMENTAL
Intervention: Nicotine gum (6 mg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 2
Study: 32326347

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei HA-196 (n = 84)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum R0175 (n = 83)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo (n = 81)
Number of subjects: 251
Study: 33651733

Group type: EXPERIMENTAL
Intervention: Treadmill GXT
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cycle GXT
Number of subjects: 31
Study: 32792358

Group type: EXPERIMENTAL
Intervention: Immune-checkpoint-blockade (ICB) treatment
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Combinatorial biomarker of tumor mutational burden (TMB) and CNA
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Lower burden of CNA
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: CNA burden
Number of subjects: 93
Study: 35792746

Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine (3 doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BA.1 convalescent sera
Number of subjects: 0
Study: 33518304

Group type: COMPARATOR
Intervention: n-3 fatty acids during the grower phase (11-24 d)
Number of subjects: 210

Group type: COMPARATOR
Intervention: n-3 fatty acids during the starter phase (0-10 d)
Number of subjects: 210

Group type: COMPARATOR
Intervention: VE (200 IU/kg) and n-3 fatty acids during the grower phase (11-24 d)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Combination of VE and n-3 fatty acids
Number of subjects: 210

Group type: COMPARATOR
Intervention: VE during the starter phase (0-10 d)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (corn-soybean meal-basal diet)
Number of subjects: 210
Study: 32139502

Group type: EXPERIMENTAL
Intervention: Higher IOP fluctuation
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Greater mean IOP reduction post-trabeculectomy
Number of subjects: 127

Group type: COMPARATOR
Intervention: Intra-operative 5-FU
Number of subjects: 127
Study: 35276809

Group type: EXPERIMENTAL
Intervention: Food and Nutrition Education Program with Sensory and Cognitive Exercises
Number of subjects: 37

Group type: COMPARATOR
Intervention: Waiting period (control group)
Number of subjects: 37
Study: 33759640

Group type: EXPERIMENTAL
Intervention: Methanol-gasoline blend 12% (M12)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Methanol-gasoline blends (0%, 3%, 6%, 9%, 12%, 15%, 18%)
Number of subjects: 1
Study: 32702891

Group type: EXPERIMENTAL
Intervention: Epidural steroid injection (1 mL of 0.5% bupivacaine and 10 mg of triamcinolone acetonide)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (1 mL of 0.5% bupivacaine and 1 mL of normal saline)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epidural steroid injection
Number of subjects: 90
Study: 35380473

Group type: EXPERIMENTAL
Intervention: Fasted (24 h)
Number of subjects: 25
Study: 34542418

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy using VR in the form of head-mounted displays (HMDs)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Reminiscence therapy using a laptop computer supplemented by physical items (active control)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pooled apathy scores in the two intervention groups (VR and laptop)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (cognition and depression)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: VR group
Number of subjects: 43
Study: 32353573

Group type: EXPERIMENTAL
Intervention: In-person counseling (PE)
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Computer-generated written feedback (CO)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Assessment only (AO)
Number of subjects: 960
Study: 36399349

Group type: EXPERIMENTAL
Intervention: Use of a barrier membrane with a mixture of mineralized and demineralized allografts
Number of subjects: 33

Group type: COMPARATOR
Intervention: Mixture of mineralized and demineralized allografts without barrier membrane
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Modified plaque index at T0
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Keratinized mucosa width
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Gender (women)
Number of subjects: 33
Study: 33993175

Group type: EXPERIMENTAL
Intervention: Nondysmorphic pelvises
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Dysmorphic pelvises
Number of subjects: 267
Study: 32666477

Group type: EXPERIMENTAL
Intervention: UDCA (ursodeoxycholic acid)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 36111378

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.50 μg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nalbuphine 0.08 mg/kg
Number of subjects: 80
Study: 34126774

Group type: EXPERIMENTAL
Intervention: Mobile application-based health SBIRT
Number of subjects: 12

Group type: COMPARATOR
Intervention: SBIRT-Conventional Training and Supervision
Number of subjects: 12
Study: 36088659

Group type: EXPERIMENTAL
Intervention: Taste-neutral (water)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Bitter (quinine)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Sweet (saccharin)
Number of subjects: 297

Group type: COMPARATOR
Intervention: No placebo drops
Number of subjects: 297
Study: 33060389

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) with a balloon‐expandable valve
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 0
Study: 33586453

Group type: EXPERIMENTAL
Intervention: Pre-ICH antiplatelet therapy
Number of subjects: 2325

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 2325
Study: 32486805

Group type: EXPERIMENTAL
Intervention: Auditory-Visual (AV) conditions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Auditory-Only (AO) conditions
Number of subjects: 12
Study: 33676009

Group type: EXPERIMENTAL
Intervention: Active medial prefrontal cortex high-definition transcranial direct current stimulation (HD-tDCS) for 3 consecutive days (20 minutes each session)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham medial prefrontal cortex high-definition transcranial direct current stimulation (HD-tDCS) for 3 consecutive days (20 minutes each session)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 12
Study: 33994515

Group type: EXPERIMENTAL
Intervention: Home-visit occupational therapy using Management Tool for Daily Life Performance (MTDLP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Home-visit occupational therapy without using MTDLP (Control)
Number of subjects: 60
Study: 32558913

Group type: EXPERIMENTAL
Intervention: Mouth Care Without a Battle program
Number of subjects: 2152

Group type: COMPARATOR
Intervention: Standard mouth care (control)
Number of subjects: 2152
Study: 32972114

Group type: EXPERIMENTAL
Intervention: Post-Stupp protocol (concomitant chemoradiation)
Number of subjects: 6390

Group type: COMPARATOR
Intervention: Pre-Stupp protocol (no concomitant chemoradiation)
Number of subjects: 6390
Study: 32363944

Group type: EXPERIMENTAL
Intervention: Transtheoretical model‐based walking exercise training
Number of subjects: 152
Study: 33028623

Group type: EXPERIMENTAL
Intervention: Primary debulking surgery (arm A)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy followed by interval debulking surgery (arm B)
Number of subjects: 171
Study: 33549429

Group type: EXPERIMENTAL
Intervention: Virgin coconut oil (VCO) 30 ml per day for four weeks
Number of subjects: 48
Study: 36305459

Group type: EXPERIMENTAL
Intervention: Conventional therapeutic plasma exchange (TPE) with albumin replacement
Number of subjects: 1283

Group type: EXPERIMENTAL
Intervention: Low-volume plasma exchange (LVPE) with albumin replacement
Number of subjects: 1283

Group type: COMPARATOR
Intervention: Placebo (sham PE treatment)
Number of subjects: 1283

Group type: EXPERIMENTAL
Intervention: Central venous access in active treatment groups
Number of subjects: 1283

Group type: EXPERIMENTAL
Intervention: Peripheral venous access in active treatment groups
Number of subjects: 1283
Study: 34905446

Group type: EXPERIMENTAL
Intervention: EV71 vaccine (dose 1) and MMR on d 0 and EV71 vaccine (dose 2) and LA‐JEV on d 30 (Group 1)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Administration of doses 1 and 2 of EV71 vaccine on d 0 and 30, respectively (Group 3)
Number of subjects: 372

Group type: COMPARATOR
Intervention: MMR and LA‐JEV on d 0 and 30, respectively (Group 2)
Number of subjects: 372
Study: 32960998

Group type: EXPERIMENTAL
Intervention: eDiary documentation of bowel movements and fecal incontinence episodes, prompted by twice-daily phone notifications, with adherence rates of 95% and notifications prompting 29.6% of entries.
Number of subjects: 60

Group type: COMPARATOR
Intervention: paper diary documentation of bowel movements and fecal incontinence episodes.
Number of subjects: 60
Study: 34711086

Group type: EXPERIMENTAL
Intervention: Lower portion of the yellow zone (YZ)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Upper portion of the red zone (RZ)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Green zone (GZ)
Number of subjects: 120
Study: 32653952

Group type: EXPERIMENTAL
Intervention: Bell-shaped flow rate curve
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Prolonged flow rate curve
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Fluctuating flow rate curve
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Intermittent flow rate curve
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Plateau flow rate curve
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Normal voiding urodynamics
Number of subjects: 250
Study: 32534658

Group type: EXPERIMENTAL
Intervention: Postoperative poor sleep quality (measured by Pittsburgh Sleep Quality Index)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Preoperative state anxiety
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Body mass index > 30 kg/m2
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Sedentary lifestyle
Number of subjects: 400
Study: 35442771

Group type: EXPERIMENTAL
Intervention: HA‐GB (hyaluronic acid and ginkgo biloba) eyedrops 3 times a day for 4 weeks
Number of subjects: 40
Study: 32487163

Group type: EXPERIMENTAL
Intervention: multimodal hand therapy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: therapeutic ultrasound
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: combination therapy with both hand therapy and ultrasound therapy
Number of subjects: 150
Study: 35745231

Group type: EXPERIMENTAL
Intervention: Nutraceutical supplements (omega‐3 fatty acids, anthocyanins, and alpha‐cyclodextrins) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutraceutical supplements
Number of subjects: 0
Study: 33631287

Group type: EXPERIMENTAL
Intervention: Soluble interleukin-6 receptor (sIL-6R)
Number of subjects: 89119

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) and soluble glycoprotein 130 (sgp130)
Number of subjects: 89119
Study: 33404760

Group type: EXPERIMENTAL
Intervention: Subgingival air polishing with erythritol powder
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ultrasonic instrumentation
Number of subjects: 40
Study: 32475634

Group type: EXPERIMENTAL
Intervention: Modern radiotherapy delivery systems and treatment strategies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional workflows for the management of patients requiring dentoalveolar surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomised trial
Number of subjects: 0
Study: 34806342

Group type: EXPERIMENTAL
Intervention: Sinovac-CoronaVac vaccine
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: HCQ monotherapy
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Prednisone and MMF
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Safety analysis
Number of subjects: 290
Study: 33506858

Group type: EXPERIMENTAL
Intervention: Nudge (providing a paper form for free vaccine delivery and contacts for occupational health services)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: No nudge
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 161
Study: 32711523

Group type: COMPARATOR
Intervention: Melbourne INFANT Program (15-month, six session program)
Number of subjects: 480
Study: 36151280

Group type: EXPERIMENTAL
Intervention: Dentapen infiltration (slow flow rate of 1.8 mL/162 sec, ramp-up mode)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Traditional syringe infiltration (flow rate of 1.8 ml/60 sec)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Dentapen infiltration
Number of subjects: 130
Study: 32876655

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 96
Study: 33647762

Group type: EXPERIMENTAL
Intervention: High heat capacity mattress (HHCM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low heat capacity mattress (LHCM)
Number of subjects: 24
Study: 32592830

Group type: COMPARATOR
Intervention: Traditional resistance training (TRT)
Number of subjects: 66
Study: 36055941

Group type: EXPERIMENTAL
Intervention: Lidocaine spray
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ice spray
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 90
Study: 33402161

Group type: EXPERIMENTAL
Intervention: eHealth intervention involving a tailored physical activity and progressive resistance exercise program remotely delivered by a physiotherapist
Number of subjects: 156

Group type: COMPARATOR
Intervention: Usual care involving referral to a range of care practices in the community
Number of subjects: 156
Study: 32449003

Group type: EXPERIMENTAL
Intervention: FOLFOXIRI with panitumumab
Number of subjects: 66

Group type: COMPARATOR
Intervention: FOLFOXIRI without panitumumab
Number of subjects: 66
Study: 36385033

Group type: EXPERIMENTAL
Intervention: New thrombectomy device - multisegment Mechanical Thrombectomy (MT) System
Number of subjects: 238

Group type: COMPARATOR
Intervention: Solitare FR
Number of subjects: 238
Study: 33715279

Group type: EXPERIMENTAL
Intervention: DBBMC-EMD (test)
Number of subjects: 42

Group type: COMPARATOR
Intervention: DBBMC (control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups (DBBMC and DBBMC-EMD)
Number of subjects: 42
Study: 32060078

Group type: EXPERIMENTAL
Intervention: Stellant FLEX injector
Number of subjects: 10

Group type: COMPARATOR
Intervention: Stellant injector
Number of subjects: 10
Study: 36251060

Group type: EXPERIMENTAL
Intervention: Diffusion Tensor Imaging (DTI)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Proton Magnetic Resonance Spectroscopy (1H-MRS)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Serum Neuron-Specific Enolase (NSE)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Motor Score at 72 hours
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Combination of FA, tNAA/tCr, NSE, motor score, and Epileptic Seizures (ES)
Number of subjects: 92
Study: 33070354

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) (0.12%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride (CPC) (0.05%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salt and water (NaCl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no rinse)
Number of subjects: 0
Study: 33993473

Group type: EXPERIMENTAL
Intervention: Propofol infusion (1.0 mg/kg/h after a loading dose of 0.3 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 0
Study: 33826861

Group type: EXPERIMENTAL
Intervention: AppCoach
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: AppAlone
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control
Number of subjects: 3
Study: 32771434

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 3786

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 3786